It’s an intriguing prospect - especially with its Alzheimer medication.... if it’s pipeline concerning the debilitating neurological diseases does click then the returns could be astronomical. I'm in for a smallish position and will be adding more!This quote is hidden because you are ignoring this member. Show Quote